147438-30-0.: Everolimus Related Compound 3

Everolimus Related Compound 3 (CAS No: 147438-30-0) or (S)-1-(2-((2R,3R,6S)-6-((2S,3E,5E,7E,9S,11R)-2,13-dimethoxy-3,9,11-trimethyl-12-oxotrideca-3,5,7-trien-1-yl)-2-hydroxy-3-methyltetrahydro-2H-pyran-2-yl)-2-oxoacetyl)piperidine-2-carboxylic acid.Everolimus is an inhibitor of mTOR. which is used in management of neuroendocrine tumors.

Additional information on CAS 147438-30-0.

Catalogue No.

VE008144

CAS No.

147438-30-0.

Molecular Formula

C32H49NO9

Molecular Weight

591.74 g/mol

Parent drug

Everolimus

IUPAC Name

(S)-1-(2-((2R, 3R, 6S)-6-((2S, 3E, 5E, 7E, 9S, 11R)-2, 13-dimethoxy-3, 9, 11-trimethyl-12-oxotrideca-3, 5, 7-trien-1-yl)-2-hydroxy-3-methyltetrahydro-2H-pyran-2-yl)-2-oxoacetyl)piperidine-2-carboxylic acid

Synonyms

N/A

References

Sci-Hub, Everolimus in the treatment of neuroendocrine tumors: efficacy, side-effects, resistance, and factors affecting its place in the treatment sequence. Expert Opinion on Pharmacotherapy, 19(8), 909–928, 10.1080/14656566.2018.1476492. (2018). Sci-Hub.se. https://sci-hub.se/10.1080/14656566.2018.1476492

Status

In-stock